BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dupixent Discussions - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dupixent Discussions
X-ORIGINAL-URL:https://www.dupixentdiscussions.com
X-WR-CALDESC:Events for Dupixent Discussions
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251002T121500
DTEND;TZID=America/New_York:20251002T131500
DTSTAMP:20260408T182122
CREATED:20250829T203258Z
LAST-MODIFIED:20250926T005252Z
UID:10000716-1759407300-1759410900@www.dupixentdiscussions.com
SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Justin Greiwe\, MD
DESCRIPTION:Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation[gravityform id=”1″ field_values=”zoomid=92185067286″]
URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-justin-greiwe-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Chronic Spontaneous Urticaria (CSU)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Justin-Greiwe-wdrEP0.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251001T121500
DTEND;TZID=America/Chicago:20251001T131500
DTSTAMP:20260408T182122
CREATED:20250829T203257Z
LAST-MODIFIED:20250919T211028Z
UID:10000715-1759320900-1759324500@www.dupixentdiscussions.com
SUMMARY:Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age by Raj Chovatiya\, MD
DESCRIPTION:Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU)\, including its clinical manifestations\, diagnostic evaluation\, assessment scales\, and a treatment option for appropriate CSU patients 12+ years of age. \n[gravityform id=”1″ field_values=”zoomid=99810660287″]
URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-raj-chovatiya-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Chronic Spontaneous Urticaria (CSU)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Raj-Chovatiya-1-e1705617016350-65OSWK.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250930T121500
DTEND;TZID=America/Los_Angeles:20250930T131500
DTSTAMP:20260408T182122
CREATED:20250829T203257Z
LAST-MODIFIED:20250926T005136Z
UID:10000714-1759234500-1759238100@www.dupixentdiscussions.com
SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Kathryn Sowerwine\, MD
DESCRIPTION:Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation[gravityform id=”1″ field_values=”zoomid=98655284668″]
URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-kathryn-sowerwine-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Chronic Spontaneous Urticaria (CSU)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Kathryn-Sowerwine-e1705692143713-eb2DRh.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250929T121500
DTEND;TZID=America/New_York:20250929T124500
DTSTAMP:20260408T182122
CREATED:20250829T203257Z
LAST-MODIFIED:20250926T005114Z
UID:10000713-1759148100-1759149900@www.dupixentdiscussions.com
SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Andrew Mastro\, PA-C
DESCRIPTION:This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. \nRegister \n 
URL:https://www.dupixentdiscussions.com/event/exploring-the-pathophysiology-of-type-2-inflammation-in-chronic-spontaneous-urticaria-csu-and-a-treatment-option-for-appropriate-csu-patients-12-years-of-age-by-andrew-mastro-pa-c/
LOCATION:Virtual (Zoom)
CATEGORIES:Chronic Spontaneous Urticaria (CSU)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Andrew-Mastro-PA-C-e1756498706590.png
END:VEVENT
END:VCALENDAR